Sherritt International Corporation (SHERF)
OTCMKTS · Delayed Price · Currency is USD
0.1000
0.00 (0.00%)
Jul 30, 2025, 8:00 PM EDT
Intra-Cellular Therapies Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Cash & Equivalents | 121.6 | 145.7 | 119.1 | 123.9 | 145.6 | 167.4 | Upgrade |
Cash & Short-Term Investments | 121.6 | 145.7 | 119.1 | 123.9 | 145.6 | 167.4 | Upgrade |
Cash Growth | -8.09% | 22.33% | -3.87% | -14.90% | -13.02% | 0.78% | Upgrade |
Receivables | 92 | 152.5 | 152 | 187.3 | 191.5 | 141.1 | Upgrade |
Inventory | 42.4 | 43.3 | 39.8 | 37.7 | 30.3 | 27 | Upgrade |
Prepaid Expenses | 9.5 | 9.4 | 7.8 | 5.1 | 4 | 3.7 | Upgrade |
Restricted Cash | 0.3 | 1.4 | 1.4 | 1.4 | 1.3 | 5.3 | Upgrade |
Other Current Assets | 25.9 | 32.5 | 78.9 | 73.9 | 17.3 | 36.8 | Upgrade |
Total Current Assets | 291.7 | 384.8 | 399 | 429.3 | 390 | 381.3 | Upgrade |
Property, Plant & Equipment | 151.6 | 152.1 | 159.2 | 148.6 | 150.9 | 166.4 | Upgrade |
Long-Term Investments | 593.1 | 665.4 | 646.7 | 756 | 642.4 | 597.4 | Upgrade |
Other Intangible Assets | 6.6 | 7.1 | 14.5 | 13.8 | 24.3 | 37.5 | Upgrade |
Long-Term Accounts Receivable | - | 0.8 | 1 | 1.9 | 2.8 | 3.7 | Upgrade |
Long-Term Deferred Tax Assets | 1.1 | 1.1 | 0.4 | - | - | - | Upgrade |
Other Long-Term Assets | 186.9 | 171.5 | 169.8 | 206 | 187.6 | 165.9 | Upgrade |
Total Assets | 1,231 | 1,383 | 1,391 | 1,556 | 1,398 | 1,352 | Upgrade |
Accounts Payable | 155.8 | 172.5 | 169.2 | 209.7 | 196 | 135 | Upgrade |
Short-Term Debt | 66.8 | - | - | 46.5 | - | 8 | Upgrade |
Current Portion of Long-Term Debt | - | 67.2 | 56.8 | - | - | - | Upgrade |
Current Portion of Leases | 2.1 | 2.8 | - | - | - | - | Upgrade |
Current Income Taxes Payable | 0.2 | 1.7 | 2.2 | 1 | 0.9 | 12.3 | Upgrade |
Current Unearned Revenue | 5.7 | 11.9 | 12.2 | 12.9 | 14.4 | 7.5 | Upgrade |
Other Current Liabilities | 17.8 | 36.9 | 46.9 | 97.5 | 10.6 | 6.7 | Upgrade |
Total Current Liabilities | 248.4 | 293 | 287.3 | 367.6 | 221.9 | 169.5 | Upgrade |
Long-Term Debt | 248.9 | 305.3 | 298.8 | 304.4 | 444.5 | 433.4 | Upgrade |
Long-Term Leases | 8 | 8.8 | 11 | - | - | 15.7 | Upgrade |
Long-Term Deferred Tax Liabilities | 0.9 | 0.9 | 0.6 | 0.4 | 1.6 | 1.4 | Upgrade |
Other Long-Term Liabilities | 180.6 | 177.4 | 179.3 | 188.3 | 145 | 125.4 | Upgrade |
Total Liabilities | 686.8 | 785.4 | 777 | 860.7 | 813 | 745.4 | Upgrade |
Common Stock | 2,909 | 2,895 | 2,895 | 2,895 | 2,895 | 2,895 | Upgrade |
Retained Earnings | -3,003 | -2,972 | -2,900 | -2,835 | -2,899 | -2,880 | Upgrade |
Comprehensive Income & Other | 638.2 | 674.9 | 618.3 | 635 | 588.6 | 592 | Upgrade |
Shareholders' Equity | 544.2 | 597.4 | 613.6 | 694.9 | 585 | 606.8 | Upgrade |
Total Liabilities & Equity | 1,231 | 1,383 | 1,391 | 1,556 | 1,398 | 1,352 | Upgrade |
Total Debt | 325.8 | 384.1 | 366.6 | 350.9 | 444.5 | 457.1 | Upgrade |
Net Cash (Debt) | -204.2 | -238.4 | -247.5 | -227 | -298.9 | -289.7 | Upgrade |
Net Cash Per Share | -0.49 | -0.60 | -0.62 | -0.57 | -0.75 | -0.73 | Upgrade |
Filing Date Shares Outstanding | 496.29 | 397.29 | 397.29 | 397.29 | 397.29 | 397.28 | Upgrade |
Total Common Shares Outstanding | 496.29 | 397.29 | 397.29 | 397.29 | 397.29 | 397.28 | Upgrade |
Working Capital | 43.3 | 91.8 | 111.7 | 61.7 | 168.1 | 211.8 | Upgrade |
Book Value Per Share | 1.10 | 1.50 | 1.54 | 1.75 | 1.47 | 1.53 | Upgrade |
Tangible Book Value | 537.6 | 590.3 | 599.1 | 681.1 | 560.7 | 569.3 | Upgrade |
Tangible Book Value Per Share | 1.08 | 1.49 | 1.51 | 1.71 | 1.41 | 1.43 | Upgrade |
Machinery | - | 651.3 | 622.8 | 608.2 | 584 | 679 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.